Revvity | PKI - Operating Expenses


Revvity reported $628.34M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Agilent USD 1.44B 9M Mar/2026
Align Technology USD 862.03M 39.18M Mar/2026
Bio Techne USD 235.92M 5.5M Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
Bruker USD 813.2M 87.7M Mar/2026
Celltrion KRW 140.68B 584.31B Dec/2025
Charles River Laboratories USD 875.93M 42.48M Mar/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 1.32B 895M Mar/2026
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Divis Laboratories Ltd INR 20.17B 1.85B Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Illumina USD 852M 51M Mar/2026
Intuitive Surgical USD 1.91B 89.8M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Kangmei Pharma CNY 1.09B 304.02M Mar/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Laboratory Of America USD 3.13B 6.3M Mar/2026
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 21.61M 11.59M Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Mettler Toledo International USD 713.2M 64.61M Mar/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Organigram Holdings CAD 83.66M 24.44M Dec/2025
Ovoca Bio EUR 1.16M 4.48M Jun/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Pharma Mar EUR 42.28M 4.59M Mar/2026
Qiagen NV USD 418.54M 23.25M Dec/2025
Quest Diagnostics USD 2.5B 76M Mar/2026
Quidel USD 1.85B 1.09B Mar/2026
Repligen USD 174.27M 3.67M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Sartorius EUR 738.4M 22.4M Mar/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Tilray USD 237.52M 17.34M Sep/2025
Waters USD 1.12B 457.15M Mar/2026
Zealand Pharma A/S 775.97M 265.08M Dec/2025
Zz Pientze Pharmaceu CNY 1.88B 326.34M Mar/2026